Protagonist Therapeutics
PTGX
#2579
Rank
โ‚ฌ5.73 B
Marketcap
89,88ย โ‚ฌ
Share price
0.11%
Change (1 day)
105.94%
Change (1 year)

Revenue for Protagonist Therapeutics (PTGX)

Revenue in 2025 (TTM): โ‚ฌ41.22 Million

According to Protagonist Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ39.85 Million. a decrease over the revenue in the year 2024 that were of โ‚ฌ0.41 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Protagonist Therapeutics from 2015 to 2025

Annual revenue

Year Revenue Change
2025 โ‚ฌ39.17 M-90.62%
2024 โ‚ฌ0.41 B669.17%
2023 โ‚ฌ54.27 M119.03%
2022 โ‚ฌ24.78 M2.58%
2021 โ‚ฌ24.15 M3.79%
2020 โ‚ฌ23.27 M11187.16%
2019 โ‚ฌ0.2 M-99.24%
2018 โ‚ฌ27.03 M61.67%
2017 โ‚ฌ16.72 M
2016 N/A
2015 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA